The Asia-Pacific contract research organization market was valued at US$ 8,112.00 million in 2020 and it is projected to reach US$ 18,399.87 million by 2028; it is expected to grow at a CAGR of 11.2% during 2021–2028.
Contract research organization (CRO) provides support services to the pharmaceutical, biotechnology, and medical device companies throughout the development of the product. Pharmaceutical& biotechnology companies and the medical device industry require various testing services such as preclinical services, clinical research services, analytical testing services, bioanalytical testing services, and regulatory services. CROs are specifically designed to perform these testing services to reduce the in-house cost and time of the companies, required to conduct the extensive range of testing services to comply with the national and international regulatory standards.
The Asian continent appears to be a rapidly growing destination for conduction of cost-effective clinical trials. Moreover, the ease of regulatory compliance and presence of top clinical institutions further contributes to Asia-Pacific becoming the new choice of destination for conduction of clinical trials. Outsourcing is an integral part of the biopharmaceutical industry primarily during the clinical phases of the research and development (R&D). The rising number of clinical trials in the region also attributes to the presence and easy access of treatment-naïve patient pool.
The high incidence of diseases such as hepatitis, stroke, and lung cancer make Asia-Pacific a promising destination for conduction of clinical trials. According to a World Health Organization (WHO) database study, the total number of registered clinical trials in the Asia Pacific between 2009 and 2018 were reported to be more than 125,000. This implies a 7-fold increase in the total number of clinical trials in Asian region. The report also suggests that Japan conducted highest number of clinical trials, which is approximately 30.8% of the total trials held in the region. The annual average increase in the number of clinical trials in Asia-Pacific is greater than the US, Canada, and EU countries. According to a report published by PubMed in September 2019, Iran recorded the highest annual increase in the number of clinical trials in Asia with 41% increase in 2019 as compared to 2018. Thus, the increasing number of clinical trials in the region implies the increasing demand for outsourcing research and development activities thereby responsible for the growth of the contract research organization (CROs) market in Asia-Pacific during the forecast years.
Market Insights
Research and development (R&D) is an essential and crucial part of the company’s business. Pharmaceutical and biotech companies focus on the research and development (R&D) to come up with new molecules for various therapeutic applications with the greatest medical and commercial potential. The companies invest majorly on the R&Ds with the aim of delivering high quality and innovative products to the market. R&D spending by the biopharmaceutical companies has also increased over the years. In addition, the rapid growth of Asian biopharmaceutical industry has created a community for investors that has plenty of capital. According to a report published in Top 10 Asia Biopharma Clusters 2018, the Asian investors contributed to approximately US$ 4.2 billion in biopharmaceutical start-ups attributing to their high potential for expansion in the coming years
Type: Insights
The Asia-Pacific contract research organization market, based on type, is bifurcated into early phase development services, clinical research services, laboratory services, and post-approval services. The clinical research services segment held a larger share of the market in 2020. However, the same segment is expected to register a higher CAGR in the market during the forecast period.
Asia-Pacific contract research organization Market, by Type – 2020 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
End User:
Based on end user, the Asia-Pacific contract research organization market is segmented into pharmaceutical and biotechnology companies and medical device companies. The pharmaceutical and biotechnology companies segment held the largest share of the market in 2020, and the same segment is expected to register the highest CAGR during 2021–2028.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Asia Pacific Contract Research Organization (CRO) Market: Strategic Insights
Market Size Value in US$ 8,112.00 Million in 2020 Market Size Value by US$ 18,399.87 Million by 2028 Growth rate CAGR of 11.2% from 2021-2028 Forecast Period 2021-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Asia Pacific Contract Research Organization (CRO) Market: Strategic Insights
| Market Size Value in | US$ 8,112.00 Million in 2020 |
| Market Size Value by | US$ 18,399.87 Million by 2028 |
| Growth rate | CAGR of 11.2% from 2021-2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Players operating in the Asia-Pacific contract research organization market adopt collaboration and partnership strategies to meet the demands of end users through the introduction of technologically advanced offerings, and these strategies significantly support the growth of the market.
By Type
- Early Phase Development Services
- Drug Discovery Services
- Pre-Clinical Services
- Clinical Research Services
- Laboratory Services
- Post-Approval Services
By End User
- Pharmaceutical and Biotechnology Companies
- Medical Device Companies
By Country
- China
- India
- South Korea
- Japan
- Australia
Company Profiles
- IQVIA Inc.
- Parexel International Corporation
- Charles River Laboratories, Inc.
- ACM Global Laboratories
- Merck KGaA (Bio Reliance Corporation)
- Celerion
- Clinitude
- Laboratory Corporation of America Holdings (Covance Inc.)
- Novotech
- Icon PLC
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, End User and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, India, Japan, RoAPAC, South Korea
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia-Pacific Contract Research Organization Market – By Type
1.3.2 Asia-Pacific Contract Research Organization Market – By End User
1.3.3 Asia-Pacific Contract Research Organization Market– By Geography
2. Contract Research Organization Market– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia-Pacific Contract Research Organization Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 APAC PEST Analysis
4.3 Expert Opinion
4.4 Pharmaceutical Drugs Market Forecast and Analysis, By Region
4.5 Global R&D Spend by Pharmaceutical and Biotechnology Companies, Forecast To 2028
4.6 Global Outsourcing Scenario (Qualitative Insights)
5. Contract Research Organization Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing R&D Expenditures and Outsourcing Activities
5.1.2 Increasing Number of Clinical Trials in Asia Pacific
5.2 Market Restraint
5.2.1 Availability of Skilled Professionals
5.3 Market Opportunity
5.3.1 Rising Demand for Specialized Testing Services
5.4 Future Trend
5.4.1 Rising Market Consolidation
5.5 Impact analysis
6. Contract Research Organization Market– Asia-Pacific Analysis
6.1 Asia-Pacific Contract Research Organization Market Revenue Forecast and Analysis
6.2 Market Positioning of Key Players
7. Contract Research Organization (CRO) Market Analysis – By Type
7.1 Overview
7.2 Contract Research Organization (CRO) Market Revenue Share, by Type (2020–2028)
7.3 Early Phase Development Services
7.3.1 Overview
7.3.2 Early Phase Development Services: Contract Research Organization (CRO) Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Drug Discovery Services Market
7.3.3.1 Overview
7.3.3.2 Drug Discovery Services: Contract Research Organization (CRO) Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Pre-Clinical Services Market
7.3.4.1 Overview
7.3.4.2 Pre-Clinical Services: Contract Research Organization (CRO) Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Clinical Research Services
7.4.1 Overview
7.4.2 Clinical Research Services: Contract Research Organization (CRO) Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Laboratory Services
7.5.1 Overview
7.5.2 Laboratory Services: Contract Research Organization (CRO) Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Post-Approval Services
7.6.1 Overview
7.6.2 Post-Approval Services: Contract Research Organization (CRO) Market – Revenue and Forecast to 2028 (US$ Million)
8. Contract Research Organization (CRO) Market Analysis – By End User
8.1 Overview
8.2 Contract Research Organization (CRO) Market Revenue Share, by End User (2020–2028)
8.3 Pharmaceutical and Biotechnology Companies
8.3.1 Overview
8.3.2 Pharmaceutical and Biotechnology Companies: Contract Research Organization (CRO) Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Medical Device Companies
8.4.1 Overview
8.4.2 Medical Device Companies: Contract Research Organization (CRO) Market – Revenue and Forecast to 2028 (US$ Million)
9. Contract Research Organization Market Analysis and Forecasts To 2028 – Geographical Analysis
9.1 Asia-Pacific: Contract Research Organization Market
9.1.1 Overview
9.1.2 Asia-Pacific: Contract Research Organization Market - Revenue and Forecast to 2028 (USD Million)
9.1.3 Asia-Pacific: Contract Research Organization Market, by Type, 2019–2028 (USD Million)
9.1.3.1.1 Asia-Pacific: Early Phase Development Services Market, by Type, 2019–2028 (USD Million)
9.1.4 Asia-Pacific: Contract Research Organization Market, by End User, 2019–2028 (USD Million)
9.1.5 Asia-Pacific: Contract Research Organization Market, by Country, 2020 & 2028 (%)
9.1.6 China: Contract Research Organization Market – Revenue and Forecast to 2028 (USD Million)
9.1.6.1 China: Contract Research Organization Market – Revenue and Forecast to 2028 (USD Million)
9.1.6.2 China: Contract Research Organization Market, by Type, 2019–2028 (USD Million)
9.1.6.2.1 China: Early Phase Development Services Market, by Type, 2019–2028 (USD Million)
9.1.6.2.2 China: Imaging Tests Market, by End User, 2019–2028 (USD Million)
9.1.6.3 Japan: Contract Research Organization Market – Revenue and Forecast to 2028 (USD Million)
9.1.6.4 Japan: Contract Research Organization Market – Revenue and Forecast to 2028 (USD Million)
9.1.6.5 Japan: Contract Research Organization Market, by Type, 2019–2028 (USD Million)
9.1.6.5.1 Japan: Early Phase Development Services Market, by Type, 2019–2028 (USD Million)
9.1.6.6 Japan: Contract Research Organization Market, by End User, 2019–2028 (USD Million)
9.1.7 India: Contract Research Organization Market – Revenue and Forecast to 2028 (USD Million)
9.1.7.1 India: Contract Research Organization Market – Revenue and Forecast to 2028 (USD Million)
9.1.7.2 India: Contract Research Organization Market, by Type, 2019–2028 (USD Million)
9.1.7.2.1 India: Early Phase Development Services Market, by Type, 2019–2028 (USD Million)
9.1.7.3 India: Contract Research Organization Market, by End User, 2019–2028 (USD Million)
9.1.8 Australia: Contract Research Organization Market – Revenue and Forecast to 2028 (USD Million)
9.1.8.1 Australia: Contract Research Organization Market – Revenue and Forecast to 2028 (USD Million)
9.1.8.2 Australia: Contract Research Organization Market, by Type, 2019–2028 (USD Million)
9.1.8.2.1 Australia: Early Phase Development Services Market, by Type, 2019–2028 (USD Million)
9.1.8.3 Australia: Contract Research Organization Market, by End User, 2019–2028 (USD Million)
9.1.9 South Korea: Contract Research Organization Market – Revenue and Forecast to 2028 (USD Million)
9.1.9.1 South Korea: Contract Research Organization Market – Revenue and Forecast to 2028 (USD Million)
9.1.9.2 South Korea: Contract Research Organization Market, by Type, 2019–2028 (USD Million)
9.1.9.2.1 South Korea: Early Phase Development Services Market, by Type, 2019–2028 (USD Million)
9.1.9.3 South Korea: Contract Research Organization Market, by End User, 2019–2028 (USD Million)
9.1.10 Rest of Asia-Pacific: Contract Research Organization Market – Revenue and Forecast to 2028 (USD Million)
9.1.10.1 Rest of Asia-Pacific: Contract Research Organization Market – Revenue and Forecast to 2028 (USD Million)
9.1.10.2 Rest of Asia-Pacific: Contract Research Organization Market, by Type, 2019–2028 (USD Million)
9.1.10.2.1 Rest of Asia-Pacific: Early Phase Development Services Market, by Type, 2019–2028 (USD Million)
9.1.10.3 Rest of Asia-Pacific: Contract Research Organization Market, by End User, 2019–2028 (USD Million)
10. Impact of COVID-19 Pandemic on Asia-Pacific Contract Research Organization Market
10.1 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11. Contract Research Organization Market– Industry Landscape
11.1 Overview
11.2 Growth Strategies in The Asia Pacific Contract Research Organization (CRO) Devices Market, 2018-2021
11.3 Organic Growth Strategies
11.3.1 Overview
11.3.2 Recent Organic Developments in the Asia Pacific Contract Research Organization (CRO) Market
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 IQVIA Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 PAREXEL INTERNATIONAL CORPORATION
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 CHARLES RIVER LABORATORIES, INC.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 ACM Global Laboratories
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 MERCK KGaA (Bio Reliance Corporation)
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Celerion
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Clinitude
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Laboratory Corporation of America Holdings (Covance Inc.)
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Novotech
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 ICON PLC
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Global Pharmaceutical Drugs Market, By Region – Revenue and Forecast to 2028 (USD Million)
Table 2. Global R&D Expenditure by Pharmaceutical and Biotechnology Companies– Revenue and Forecast to 2028 (USD Million)
Table 3. R&D Investments by Pharmaceutical Companies in Asia
Table 4. Asia-Pacific Contract Research Organization Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 5. Asia-Pacific: Early Phase Development Services Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 6. Asia-Pacific Contract Research Organization Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. China: Contract Research Organization Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. China: Early Phase Development Services Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 9. China: Imaging Tests Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 10. Japan: Contract Research Organization Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 11. Japan: Early Phase Development Services Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Japan: Contract Research Organization Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. India: R&D Spending of Indian Pharmaceutical Companies (2017)
Table 14. India: Contract Research Organization Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 15. India: Early Phase Development Services Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 16. India: Contract Research Organization Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Australia: Contract Research Organization Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 18. Australia: Early Phase Development Services Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 19. Australia: Contract Research Organization Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 20. South Korea: Contract Research Organization Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 21. South Korea: Early Phase Development Services Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 22. South Korea: Contract Research Organization Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of Asia-Pacific: Contract Research Organization Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 24. Rest of Asia-Pacific: Early Phase Development Services Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 25. Rest of Asia-Pacific: Contract Research Organization Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 26. Recent Inorganic Developments in The Asia Pacific Contract Research Organization (CRO) Market
Table 27. Glossary of Terms, Contract Research Organization Market
LIST OF FIGURES
Figure 1. Contract Research Organization Market Segmentation
Figure 2. Contract Research Organization Segmentation, By Region
Figure 3. Asia-Pacific Contract Research Organization Market Overview
Figure 4. Clinical Research Services Held Largest Share of Type Segment in Contract Research Organization Market
Figure 5. India to Show Remarkable Growth During Forecast Period
Figure 6. Asia-Pacific Contract Research Organization Market– Leading Country Markets (US$ Million)
Figure 7. Asia-Pacific Contract Research Organization Market, Industry Landscape
Figure 8. APAC: PEST Analysis
Figure 9. Contract Research Organization Market Impact Analysis of Driver and Restraints
Figure 10. Asia-Pacific Contract Research Organization Market– Revenue Forecast and Analysis – 2020- 2028
Figure 11. Market Positioning of Key Players in Asia-Pacific Contract Research Organization Market
Figure 12. Contract Research Organization (CRO) Market Revenue Share, by Type (2020–2028)
Figure 13. Early Phase Development Services: Contract Research Organization (CRO) Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Drug Discovery Services: Contract Research Organization (CRO) Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Pre-Clinical Services: Contract Research Organization (CRO) Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Clinical Research Services: Contract Research Organization (CRO) Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Laboratory Services: Contract Research Organization (CRO) Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Post-Approval Services: Contract Research Organization (CRO) Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Contract Research Organization (CRO) Market Revenue Share, by End User (2020–2028)
Figure 20. Pharmaceutical and Biotechnology Companies: Contract Research Organization (CRO) Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Medical Device Companies: Contract Research Organization (CRO) Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Asia-Pacific: Contract Research Organization Market, by Key Country – Revenue (2020) (USD Million)
Figure 23. Asia-Pacific Contract Research Organization Market Revenue and Forecast to 2027 (USD Million)
Figure 24. Asia-Pacific: Contract Research Organization Market, by Country, 2020 & 2028 (%)
Figure 25. China: Contract Research Organization Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. Japan: Contract Research Organization Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. India: Contract Research Organization Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Australia: Contract Research Organization Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. South Korea: Contract Research Organization Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. Rest of Asia-Pacific: Contract Research Organization Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. Impact of COVID-19 Pandemic on Contract Research Organization Market in Asia-Pacific Countries
Figure 32. Growth Strategies in The Asia Pacific Contract Research Organization (CRO) Devices Market, 2018-2021
The List of Companies - Asia Pacific Contract Research Organization (CRO) Market
- IQVIA Inc.
- Parexel International Corporation
- Charles River Laboratories, Inc.
- ACM Global Laboratories
- Merck KGaA (Bio Reliance Corporation)
- Celerion
- Clinitude
- Laboratory Corporation of America Holdings (Covance Inc.)
- Novotech
- Icon PLC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Asia Pacific Contract Research Organization (CRO) Market
Apr 2021
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2021
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2021
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2021
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2021
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2021
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Apr 2021
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Apr 2021
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)